100% Same

Salt CompositionEffectivenessStrength

48%

with Substitute Medicine

MoleculeSalt Composition in both

Timolol 0.5% w/v

You Searched

You Searched

Ocular T 0.5% Eye Drop

Ocular T 0.5% Eye Drop

75

15 / ml
Our Recommendation

Our Recommendation

Timozer Eye Drop 5ml (Nizer)

Timozer Eye Drop 5ml (Nizer)

Nizer

Bottle of 5 ml

584+ trust this

who

WHO GMP Certified

Doctor verified video thumbnail
All Our Medicines are
who icon

WHO GMP
Certified

return Image

15 Days Easy
Returns

Long Expiry

Long Expiry
(>8 Months)

who icon

WHO GMP
Certified

return Image

15 Days Easy
Returns

Long Expiry

Long Expiry
(>8 Months)

Delivery by

Customers also bought

More About Ocular T 0.5% Eye Drop

Ocular T
Timozer
Manufacturer Address

Manufacturer Address

CABIN NO. 3, FIRST FLOOR, INDUSTRIAL PLOT NO. 151, PHASE-1 PANCHKULA Panchkula HR 134113 IN

Frequently asked questions

Yes, both medicines have the same salt composition, dosage, and effectiveness. They work the same way in your body. The only difference is the brand — and Timozer option is much more affordable without compromising on quality
Ocular T 0.5% Eye Drop eye drops are typically used once or twice daily at regular intervals until eye pressure is controlled, then may be reduced to once daily as directed by your doctor.
Ocular T 0.5% Eye Drop lowers intraocular pressure to prevent optic nerve damage and reduce the risk of blindness, effectively managing ocular hypertension and certain types of glaucoma.
No, remove your contact lenses before using Ocular T 0.5% Eye Drop and wait 15 minutes before reinserting them. Contact your doctor if you experience persistent eye irritation.
No, do not stop using Ocular T 0.5% Eye Drop without consulting your doctor, as this may lead to uncontrolled eye pressure and increased risk of vision loss.
Seek medical advice immediately if you experience an eye infection, conjunctivitis, eyelid reaction, eye injury, or after eye surgery. Discuss the continuation of Ocular T 0.5% Eye Drop with your doctor.

Checkout Editorial Policy

References

  • Westfall TC, WestfallIn DP. Adrenergic Agonists and Antagonists. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 326

  • Robertson D, Biaggioni I. Adrenoreceptor Antagonists Drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 159

  • Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1363-64

  • Timolol maleate. Fort Worth, Texas: Alcon Laboratories Inc.; 1978 (23 Jan. 2019)

  • Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (04 Apr. 2019)

  • Central Drugs Standard Control Organisation (CDSCO) (04 Apr. 2019)

  • Timolol maleate ophthalmic solution (25 Jul. 2024)

Disclaimer

PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.

Flat Rs 100 on first app order   |    Use Code:  APP100   | 

Flat Rs 100 on first app order

USE CODE: APP100

PlatinumRx

Download Now

AppleIconPlayStoreIcon